Skip to content

Author

N. Gebauer

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

For patients with large B-cell lymphoma progressing after multiple lines of therapy few treatment options remain, including the new CD19-directed antibody-drug conjugate loncastuximab tesirine (lonca). To further elucidate its efficacy and safety, we conducted a real-world analysis including data from 31 German centers...

Evgenii Shumilov, Lina J. Kolloch, Philipp Faustmann et al. · 0 citations
Review Jul 2026

Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards.

The expanding availability of multi-omics profiling and advances in artificial intelli-gence (AI) and machine learning (ML) are changing precision oncology. Molecular testing strategies such as longitudinal liquid biopsy assessment, germline variant analysis, and the evaluation of tumor-infiltrating clonal hematopoiesi...

J. Vorwerk, L. Leypoldt, Johanna Schwandt et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.